Publication | Open Access

Pharmacokinetics and Tolerability of Vandetanib in Chinese Patients With Solid, Malignant Tumors: An Open-Label, Phase I, Rising Multiple-Dose Study

OncologyMedicineMultiple-dose StudyMalignant TumorsPharmacotherapyAnti-cancer AgentCancer TreatmentPharmacologyPharmacokineticsChinese Patients